⚠ Evidence warning: Clinical trials or other evidence do not support the claim that the evidence for N-acetylcarnosine eye drops in cataract is promising. This page keeps it as a report of what people, websites or other media say.

Cataracts

👁️ Interactive Visualization Vision & the Retina — focus light and watch rods fire Follow the phototransduction cascade as rods and cones react, then dim the lights and watch the eye adapt. Launch →

How Cataracts Form
Types of Cataracts
Risk Factors
Symptoms and Progression
Conventional Treatment
Natural Prevention and Support
Foods for Eye Health
Lifestyle Protection
The Role of Antioxidants
Cautions and Considerations
Key Research Papers
Featured Videos

1. How Cataracts Form

A cataract is a clouding of the eye's natural crystalline lens, which sits behind the iris and pupil. The lens, normally clear, focuses light onto the retina to produce sharp images. When proteins in the lens break down and clump together, they create opaque areas that scatter light and progressively blur vision.

Cataracts are the leading cause of blindness worldwide and affect more than half of all Americans by age 80. From a naturopathic perspective, cataract formation is closely linked to cumulative oxidative stress, nutrient depletion, and chronic exposure to environmental toxins. While surgery remains the definitive treatment for advanced cataracts, a proactive approach focused on antioxidant nutrition and lifestyle protection may significantly delay their onset and slow progression.

2. Types of Cataracts

Nuclear Cataracts

Form in the center (nucleus) of the lens.
The most common age-related type.
Initially may cause a temporary improvement in near vision ("second sight") before worsening.
The lens gradually yellows and hardens, eventually turning brown in advanced stages.

Cortical Cataracts

Begin as whitish, wedge-shaped opacities on the outer edge (cortex) of the lens.
Slowly extend inward in a spoke-like pattern toward the center.
Often cause problems with glare and light scatter, particularly while driving at night.
More common in individuals with diabetes.

Posterior Subcapsular Cataracts

Form as a small, opaque area on the back surface of the lens, directly in the path of light.
Tend to progress more rapidly than other types.
Cause significant difficulty with reading and bright light.
Strongly associated with corticosteroid use, diabetes, and high myopia.

3. Risk Factors

Age: The single greatest risk factor; lens proteins degrade over decades of oxidative exposure.
Ultraviolet (UV) radiation: Chronic sun exposure accelerates oxidative damage to lens proteins.
Diabetes: Elevated blood sugar promotes glycation of lens proteins and builds up sorbitol inside the lens, which draws in water (osmotic stress).
Smoking: Generates massive free radical load and depletes protective antioxidants (especially vitamin C).
Corticosteroid medications: Both systemic and inhaled steroids increase cataract risk with prolonged use.
Eye trauma or surgery: Physical damage to the lens capsule can initiate cataract formation.
Alcohol consumption: Heavy drinking is associated with increased cataract risk.
Obesity: Linked to increased oxidative stress and systemic inflammation.
Family history: Genetic factors influence lens protein composition and antioxidant capacity.
Nutritional deficiencies: Low intake of antioxidant vitamins and carotenoids.

4. Symptoms and Progression

Cataracts develop gradually, and early stages may produce no noticeable symptoms. As the cataract progresses, common signs include:

Blurred or cloudy vision: As if looking through a foggy or dusty window.
Increased sensitivity to glare: Headlights and sunlight become uncomfortably bright.
Halos around lights: Especially noticeable at night.
Fading or yellowing of colors: Colors appear less vivid or take on a brownish tint.
Frequent prescription changes: Glasses or contacts need updating more often.
Difficulty with night vision: Reduced contrast sensitivity in low-light conditions.
Double vision in one eye: The cataract may split light entering the lens.

Progression varies widely. Some cataracts remain stable for years, while others advance rapidly. Regular eye examinations allow your doctor to monitor changes and determine the optimal timing for intervention.

5. Conventional Treatment

The only definitive treatment for cataracts is surgical removal of the clouded lens and replacement with an artificial intraocular lens (IOL).

Phacoemulsification: The most common technique; uses ultrasound energy to break up the lens, which is then aspirated through a small incision.
Extracapsular extraction: Used for very advanced cataracts; involves a larger incision to remove the lens in one piece.
Intraocular lens options: Monofocal, multifocal, and toric (astigmatism-correcting) lenses are available.
Surgery timing: Usually offered when cataracts interfere significantly with daily activities, driving, or quality of life.

Cataract surgery is one of the most commonly performed and safest surgeries, with a success rate exceeding 95%. Naturopathic practitioners describe prevention as a way to delay the need for surgery.

6. Natural Prevention and Support

Practitioners use the following nutrients and natural compounds to protect the lens from oxidative damage and slow cataract progression. Where large randomized trials have tested them, the results are given under each heading.

Lutein and Zeaxanthin

Carotenoid pigments that concentrate in the lens and retina, acting as natural blue-light filters.
Neutralize free radicals generated by light exposure.
Higher dietary intake is consistently associated with reduced cataract risk in large population studies.
Typical dose: 10 mg lutein and 2 mg zeaxanthin daily.
In the AREDS2 trial, 3,159 adults aged 50 to 85 took 10 mg lutein and 2 mg zeaxanthin daily or no lutein/zeaxanthin (median follow-up 4.7 years). The supplement had no statistically significant overall effect on the need for cataract surgery (hazard ratio 0.96); without it, 24% reached cataract surgery within 5 years. In the fifth of participants who ate the least lutein and zeaxanthin, the supplement group had a lower risk of cataract surgery (hazard ratio 0.68).

Vitamin C

The lens contains one of the highest concentrations of vitamin C in the body.
Acts as a primary water-soluble antioxidant, protecting lens proteins from oxidative damage.
Population studies have linked higher vitamin C intake with fewer cataracts, but randomized supplement trials did not show a benefit. In the AREDS trial, 4,629 people aged 55 to 80 took vitamin C 500 mg, vitamin E 400 IU and beta-carotene 15 mg daily or no antioxidants for an average of 6.3 years; the combination had no statistically significant effect on the development or progression of lens clouding (odds ratio 0.97) or on cataract surgery.
In the Physicians' Health Study II, 11,545 male doctors aged 50 or older without cataract took 500 mg vitamin C daily and 400 IU vitamin E every other day, or placebos, for 8 years. Among 1,174 cataracts, the numbers were nearly the same with and without vitamin C (hazard ratio 1.02) and with and without vitamin E (hazard ratio 0.99).
Typical dose: 500-1,000 mg daily.

Vitamin E

A fat-soluble antioxidant that protects cell membranes in the lens from lipid peroxidation.
Works synergistically with vitamin C to recycle antioxidant defenses.
Neither the AREDS trial nor the Physicians' Health Study II found a cataract benefit from vitamin E supplements (see Vitamin C above).
Typical dose: 200-400 international units (IU) natural mixed tocopherols daily.

N-Acetylcarnosine Eye Drops

A prodrug form of L-carnosine that penetrates the aqueous humor.
Acts as an anti-glycation agent, helping to prevent cross-linking of lens proteins.
Studies by one research group reported improvement in lens transparency and visual acuity with regular use. A 2017 Cochrane review found two potentially eligible trials (114 people, from Russia and the United States) whose design could not be checked, and concluded there is currently no convincing evidence that N-acetylcarnosine drops reverse cataract or prevent its progression.
Typical use: 1-2 drops per eye, twice daily.

Bilberry (Vaccinium myrtillus)

Rich in anthocyanins that strengthen capillary walls and improve microcirculation in the eye.
Provides broad-spectrum antioxidant protection for ocular tissues.
Typical dose: 160-320 mg standardized extract daily.

Glutathione

The lens depends heavily on glutathione as its primary endogenous antioxidant.
Glutathione levels in the lens decline significantly with age and cataract formation.
Precursors practitioners use to support glutathione production: N-acetyl cysteine 600-1,200 mg daily, alpha-lipoic acid 150-300 mg daily, and selenium 100-200 mcg daily.
Liposomal glutathione (250-500 mg daily) may provide direct supplementation.

7. Foods for Eye Health

Dark leafy greens (kale, spinach, collard greens): Top sources of lutein and zeaxanthin.
Citrus fruits (oranges, grapefruits, kiwi): Excellent vitamin C sources.
Bell peppers: Among the highest vitamin C content of any vegetable.
Berries (blueberries, blackberries, bilberries): Rich in anthocyanins and vitamin C.
Eggs: Highly bioavailable source of lutein and zeaxanthin (in the yolk).
Nuts and seeds (almonds, sunflower seeds, hazelnuts): Provide vitamin E and selenium.
Cold-water fatty fish (salmon, sardines): Supply omega-3 fatty acids and astaxanthin.
Cruciferous vegetables (broccoli, Brussels sprouts): Support glutathione production.
Orange and yellow vegetables (carrots, sweet potatoes, squash): Rich in beta-carotene and other carotenoids.
Green tea: Contains catechins with potent antioxidant activity.

8. Lifestyle Protection

Ultraviolet Protection

Ultraviolet-blocking sunglasses (labeled UV400 or 100% ultraviolet protection) stop ultraviolet light from reaching the lens outdoors.
Wraparound styles also block light entering from the sides.
A wide-brimmed hat adds further shade.
Ultraviolet exposure is cumulative; protection matters at every age.

Blue Light Management

Prolonged exposure to high-energy visible (blue) light from screens may contribute to oxidative stress in the lens.
Blue-light filtering glasses and screen night modes are used to cut this exposure during long screen time.
The 20-20-20 rule is a common eye-strain habit: every 20 minutes, looking at something 20 feet away for 20 seconds.

Smoking Cessation

Smoking is one of the most modifiable risk factors for cataracts.
Quitting at any age reduces the rate of further lens damage.
Even secondhand smoke exposure contributes to oxidative stress in the eye.

Blood Sugar Management

A whole-foods diet low in refined carbohydrates helps keep blood glucose stable.
Uncontrolled diabetes accelerates lens glycation and osmotic stress.

9. The Role of Antioxidants

Oxidative stress is the central mechanism driving cataract formation. The lens is uniquely vulnerable because it is continuously exposed to light and oxygen yet has no blood supply of its own, relying entirely on the aqueous humor for nutrients and antioxidant delivery.

Key antioxidant defense systems in the lens include:

Glutathione: The most critical lens antioxidant, maintaining protein transparency by preventing disulfide bond cross-linking.
Superoxide dismutase (SOD): Enzymatic defense against superoxide radicals; supported by zinc, copper, and manganese.
Catalase: Breaks down hydrogen peroxide; dependent on iron.
Vitamin C: Present at concentrations 20-70 times higher in the aqueous humor than in blood plasma.
Carotenoids: Lutein and zeaxanthin filter damaging wavelengths and quench singlet oxygen.

A naturopathic approach to cataract prevention focuses on maintaining and replenishing these defense systems through optimal nutrition, targeted supplementation, and minimizing pro-oxidant exposures (ultraviolet radiation, smoking, processed food, and environmental toxins).

10. Cautions and Considerations

No supplement can reverse an established cataract. Practitioners use natural approaches for prevention and for slowing early-stage progression.
Surgery timing: surgery is usually offered when cataracts significantly impair vision, driving safety, or quality of life. Hypermature cataracts can cause complications.
N-Acetylcarnosine eye drops are not U.S. Food and Drug Administration-approved for cataract treatment. Evidence is promising but limited. A 2017 Cochrane review found no convincing evidence that they reverse cataract or prevent its progression.
High-dose vitamin E supplementation (above 400 international units daily) has been associated with increased bleeding risk, which adds to the effect of blood-thinning medications.
Beta-carotene supplements in smokers: in a Finnish trial of 29,133 male smokers aged 50 to 69, 20 mg of beta-carotene a day for five to eight years raised lung-cancer incidence by 18% (95% confidence interval 3 to 36%). The trial tested supplements, not carotenoid-rich foods.
N-acetylcysteine (N-acetyl cysteine) may interact with nitroglycerin and certain blood pressure medications.
Supplements before surgery: some, such as high-dose vitamin E, affect bleeding, which is why eye surgeons ask about supplements and natural therapies before an operation.
Individual responses vary; no single prevention plan fits everyone.

Key Research Papers

Brian G, Taylor H. Cataract blindness—challenges for the 21st century. Bulletin of the World Health Organization. 2001;79(3):249-256. — PubMed PMID: 11285671
Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Archives of Ophthalmology. 2001;119(10):1439-1452. — doi:10.1001/archopht.119.10.1439
Jacques PF, Chylack LT. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. American Journal of Clinical Nutrition. 1991;53(1):352S-355S. — doi:10.1093/ajcn/53.1.352s
Chylack LT Jr, et al. The REACT trial: a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiology. 2002;9(1):49-80. — doi:10.1076/opep.9.1.49.1717
Christen WG, et al. Age-related cataract in a randomized trial of vitamins E and C in men. Archives of Ophthalmology. 2010;128(11):1397-1405. — doi:10.1001/archophthalmol.2010.266
Michael R, Bron AJ. The ageing lens and cataract: a model of normal and pathological ageing. Philosophical Transactions of the Royal Society B. 2011;366(1568):1278-1292. — doi:10.1098/rstb.2010.0300
Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration. JAMA. 2013;309(19):2005-2015. — doi:10.1001/jama.2013.4997
Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. The Lancet. 2017;390(10094):600-612. — doi:10.1016/s0140-6736(17)30544-5
Abraham AG, Condon NG, West Gower E. The new epidemiology of cataract. Ophthalmology Clinics of North America. 2006;19(4):415-425. — PubMed PMID: 17067897
Babizhayev MA, et al. Efficacy of N-acetylcarnosine in the treatment of cataracts. Drugs in R&D. 2002;3(2):87-103. — doi:10.2165/00126839-200203020-00004
Truscott RJW. Age-related nuclear cataract: oxidation is the key. Experimental Eye Research. 2005;80(5):709-725. — doi:10.1016/j.exer.2004.12.007
Weikel KA, et al. Nutritional modulation of cataract. Nutrition Reviews. 2014;72(1):30-47. — doi:10.1111/nure.12077
Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, SanGiovanni JP, et al. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmology. 2013;131(7):843-850. — PubMed PMID: 23645227
Dubois VD, Bastawrous A. N-acetylcarnosine (NAC) drops for age-related cataract. Cochrane Database of Systematic Reviews. 2017;2(2):CD009493. — PubMed PMID: 28245346
Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine. 1994;330(15):1029-1035. — PubMed PMID: 8127329

Historical Background

Cataracts have been recognized since antiquity. The Indian physician Sushruta described cataract surgery (couching) around 600 BCE, making it one of the earliest recorded surgical procedures. Jacques Daviel performed the first modern extracapsular cataract extraction in Paris in 1747, and Sir Harold Ridley implanted the first intraocular lens in 1949 after observing that WWII pilots tolerated acrylic fragments in their eyes.

PubMed Topic Searches

Explore current literature on cataracts via PubMed topic searches. These links open live PubMed searches for the listed keywords — results update as new studies are indexed.

Back to Table of Contents